Article in Oxidative medicine and cellular longevity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
14 authors.
Ivan SpasojevicDepartment of Medicine-Division of Oncology and Duke Cancer Institute PK/PD Core Laboratory, Duke University School of Medicine, Durham 27710, North Carolina, USA.ORCID https://orcid.org/0000-0001-9890-6246
Zhiqing HuangDivision of Reproductive Sciences, Department of Obstetrics and Gynecology, Duke Cancer Institute, Duke University School of Medicine, Durham 27710, North Carolina, USA.ORCID https://orcid.org/0000-0002-6645-6700
Welida Tamires Alves da SilvaDepartment of Medicine-Division of Oncology and Duke Cancer Institute PK/PD Core Laboratory, Duke University School of Medicine, Durham 27710, North Carolina, USA.ORCID https://orcid.org/0000-0002-4558-3188
Weina DuanDepartment of Anesthesiology, Multidisciplinary Neuroprotection Laboratories, Center for Perioperative Organ Protection, Duke University School of Medicine, Durham 27710, North Carolina, USA.ORCID https://orcid.org/0000-0002-0232-8398
Li DuDepartment of Anesthesiology, Multidisciplinary Neuroprotection Laboratories, Center for Perioperative Organ Protection, Duke University School of Medicine, Durham 27710, North Carolina, USA.ORCID https://orcid.org/0000-0001-6131-6234
Cathleen ChenDepartment of Medicine-Division of Oncology and Duke Cancer Institute PK/PD Core Laboratory, Duke University School of Medicine, Durham 27710, North Carolina, USA.ORCID https://orcid.org/0009-0009-8096-2456
Jie CaoDepartment of Medicine-Division of Oncology and Duke Cancer Institute PK/PD Core Laboratory, Duke University School of Medicine, Durham 27710, North Carolina, USA.ORCID https://orcid.org/0000-0001-9618-0680
Shasha ZhangDepartment of Anesthesiology, Multidisciplinary Neuroprotection Laboratories, Center for Perioperative Organ Protection, Duke University School of Medicine, Durham 27710, North Carolina, USA.ORCID https://orcid.org/0009-0005-2946-8648
Hannah LeeDivision of Reproductive Sciences, Department of Obstetrics and Gynecology, Duke Cancer Institute, Duke University School of Medicine, Durham 27710, North Carolina, USA.ORCID https://orcid.org/0009-0009-4527-5861
Gaomong LoDivision of Reproductive Sciences, Department of Obstetrics and Gynecology, Duke Cancer Institute, Duke University School of Medicine, Durham 27710, North Carolina, USA.ORCID https://orcid.org/0009-0001-9939-0824
Huaxin ShengDepartment of Anesthesiology, Multidisciplinary Neuroprotection Laboratories, Center for Perioperative Organ Protection, Duke University School of Medicine, Durham 27710, North Carolina, USA.ORCID https://orcid.org/0000-0002-4325-2940
Angeles Alvarez SecordDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke Cancer Institute, Duke University School of Medicine, Durham 27710, North Carolina, USA.ORCID https://orcid.org/0000-0003-0946-7662
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Numerous cellular and animal studies demonstrated the ability of redox-active Mn(III)
Indexed as
MetalloporphyrinsOvarian NeoplasmsPaclitaxelPeripheral Nervous System DiseasesAnimalsCell Line, TumorFemaleHumansMiceMetalloporphyrinsPaclitaxelBMX-001cellular and mouse tumor studiesMn porphyrinMnTnBuOE-2-PyP5+mouse neuropathy modelovarian high-grade serous CAOV2 cancerSOD mimic
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Suppression of Paclitaxel-Induced Neuropathy and Ovarian Tumor Growth by Mn Porphyrin, MnTnBuOE-2-PyP · full record | OpenQuestion